Drug Profile
Research programme: GPR88 modulators - Domain Therapeutics
Latest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator Domain Therapeutics
- Class
- Mechanism of Action GPR88 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for research development in Schizophrenia in France
- 11 Jan 2014 Early research in Schizophrenia in France (unspecified route)